Business
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of the Early Development medical device testing business of Labcorp (NYSE: LH), a leading provider of innovative and comprehensive laboratory services. This strategic move underscores NAMSA's commitment to advancing innovation and accelerating time-to-market for MedTech manufacturers worldwide.
About this update from Labcorp Holdings Inc.
[{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:8PT;FONT-FAMILY:ARIAL;COLOR:BLACK;MARGIN:0em;","val":[{"type":"text","content":"","length":0,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:8PT;FONT-FAMILY:ARIAL;COLOR:BLACK;MARGIN:0em;","val":[{"type":"text","content":"","length":0,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:8PT;FONT-FAMILY:ARIAL;COLOR:BLACK;MARGIN:0em;","val":[{"type":"text","content":"","length":0,"tagName":"p","attribs":{}}]}]}],"length":0},{"type":"text","content":"TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of the Early Development medical device testing business of Labcorp (NYSE: LH), a leading provider of innovative and comprehensive laboratory services. This strategic move underscores NAMSA's commitment to advancing innovation and accelerating time-to-market for MedTech manufacturers worldwide.","length":499,"tagName":"p"},{"type":"image","alt":"NAMSA (PRNewsfoto/North American Science Associates, LLC)","displaySize":"","headline":null,"caption":"NAMSA (PRNewsfoto/North American Science Associates, LLC)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":150,"url":"https://media.zenfs.com/en/prnewswire.com/0ae3ac6f04f58445d9e1f9837c1869bd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/D9ZIGeyL5aJuIj_cW4lbsg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI2NDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/0ae3ac6f04f58445d9e1f9837c1869bd","width":400,"height":150}},"href":"https://mma.prnewswire.com/media/2626387/North_American_Science_Associates__Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"As a result of the acquisition, NAMSA assumes the U.S. portfolio of services of Labcorp's Early Development medical device testing business, including biocompatibility testing, microbiological testing, analytical testing, and preclinical research.","length":251,"tagName":"p"},{"type":"text","content":"This acquisition stren...